Zoetis Germany News and Activities
Presence
Headquarters: Germany
Zoetis is one of the...
Zoetis is a company listed under the stock ticker ZTS (US).
Zoetis has a direct presence in 7 countries.Zoetis has 7 subsidiaries including Zoetis Canada & Latin America, Zoetis Denmark and Zoetis Diagnostics.
They are in:
- Pharmaceuticals63%
- Biotechnology25%
- Other13%
Acquisition, funding and merger involving Zoetis.
- Zoetis has announced the acquisition of Neogen (posted on March 2 2026).
Executives
View the org chart displaying its 8 main executives
Most searched biographies at Zoetis Germany
- Michael Stegemann, Chief Executive Officer
- Eva Schweitz, Diagnostic Account Manager
- Mandy Zollick, Ecommerce, Customer Insights
Popular executive movements at Zoetis
- Robert Polzer, Executive Vice President and President of Research & Development, will retire on Dec. 1, 2025 (posted on November 4 2025).
- Kevin Esch will join the company as Executive Vice President and President, Research and Development on Jan. 1, 2026 (posted on November 4 2025).
- Stephanie Tilenius will join the company as Director on Dec. 1, 2025 (posted on October 29 2025).
Create your alert
to follow the executive moves at Zoetis Germany.
Pharmaceuticals
Zoetis has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Zoetis Germany
Social media about Zoetis Germany
- Zoetis Germany on Wikipedia, Google News & Yahoo Finance
- Zoetis Germany on LinkedIn, X (Twitter) & YouTube
